CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (717,967)	$ (783,616)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	10,338	33,885
Interest expense related to amortization of non-cash discount, non-cash beneficial conversion feature and deferred financing costs	102,655	26,175
Non-cash interest and note fees paid on conversion	(43,266)
Expenses related to employee stock based compensation		7,950
Expenses related to common stock warrants issued for consulting	99,987	119,094
Non-cash fair value of common stock issued as settlement of accounts payable		43,000
Non-cash fair value of common stock issued as compensation	37,500	45,000
Non-cash fair value of preferred stock issued as compensation		37,500
Non-cash fair value of common stock in exchange for warrants		62,070
Non-cash expenses related to fair value of common stock issued in warrant exchange	65,873	81,037
Net gain on settlement of accounts payable	(17,515)	220,329
Net gain on disposition of assets	33,603
(Increase) decrease in:
Accounts receivable	1,787	336
Interest receivable	(16,000)	(16,000)
Loss on impairment	95,689
Inventories	346	860
Prepaid expenses	(5,656)	6,286
Security deposits		(2,000)
Increase (decrease) in:
Accounts payable	169,990	(344,011)
Accrued expenses	535	(147,792)
Net Cash Used by Operating Activities before Discontinued Operations	(182,101)	(609,897)
Net Cash Provided by Discontinued Operations		182,518
Net Cash Used by Operating Activities	(182,101)	(427,379)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for capital equipment	(5,475)
Net Cash Used by Investing Activities	(5,475)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of convertible promissory notes	190,000	205,000
Net Cash Provided by Financing Activities	190,000	205,000
Net Increase (Decrease) in Cash and Cash Equivalents	2,424	(223,379)
Net Cash of Deconsolidated Subsidiary
Cash and Cash Equivalents, Beginning of Period	7,565	229,944
Cash and Cash Equivalents, End of Period	9,989	7,565
Supplemental Cash Flow Disclosures:
Interest expense paid in cash
Income tax paid
NON CASH INVESTING & FINANCING ACTIVITIES:
Issuance of common stock for settlement of accounts payable		43,000
Common stock issued from stock to be issued for settlements	$ 9,000